Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Dana farber Cancer Institute Inc patents

Recent patent applications related to Dana farber Cancer Institute Inc. Dana farber Cancer Institute Inc is listed as an Agent/Assignee. Note: Dana farber Cancer Institute Inc may have other listings under different names/spellings. We're not affiliated with Dana farber Cancer Institute Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dana farber Cancer Institute Inc-related inventors




Date Dana farber Cancer Institute Inc patents (updated weekly) - BOOKMARK this page
10/12/17 new patent  Humanized cc chemokine receptor 4 (ccr4) antibodies and methods of use thereof
10/12/17 new patent  Plasmids comprising internal ribosomal entry sites and uses thereof
10/05/17Pyrimido-diazepinone compounds and methods of treating disorders
09/21/17Coated particles for drug delivery
09/21/17Class-and isoform-specific hdac inhibitors and uses thereof
09/21/17Intracellular osteopontin regulates the lineage commitment of lymphoid subsets
09/14/17Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
09/14/17Stabilized insulinotropic peptides and methods of use
08/31/17Stapled intracellular-targeting antimicrobial peptides to treat infection
08/31/17Antibody molecules to pd-1 and uses thereof
08/31/17Angiopoiten-2 biomarkers predictive of anti-immune checkpoint response
08/24/17Compositions and methods for identifying and treating cachexia or pre-cachexia
08/17/17Inhibitors of hiv-1 entry and methods of use thereof
08/17/17Thiazolyl-containing compounds for treating proliferative diseases
08/17/17Compositions and methods for identification, assessment, prevention, and treatment of t-cell exhaustion using cd39 biomarkers and modulators
08/10/17Uses of salt-inducible kinase (sik) inhibitors
08/10/17Discovery of regulatory t cells programmed to suppress an immune response
08/10/17Tumor immunity
08/03/17Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
07/27/17Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
07/27/17Biopolymer-nanoparticle composite implant for tumor cell tracking
07/20/17Small molecule inhibitors of usp1 deubiquitinating enzyme activity
07/20/17Imidazolyl kinase inhibitors and uses thereof
07/20/17Macrocyclic kinase inhibitors and uses thereof
07/13/17Methods for treating cancer
07/13/17Antibody molecules to tim-3 and uses thereof
07/06/17Antibody molecules to tim-3 and uses thereof
06/29/17Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
06/29/17P13k-mtorc1-s6k1 signaling pathway biomarkers predictive of anti-cancer responses
06/29/17Methods of determining cellular chemosensitivity
06/22/17Compositions and methods for ex vivo expansion of human hematopoietic stem/progenitor cells
06/22/17Immunogenetic restriction on elicitation of antibodies
06/08/17Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
06/08/17Methods of determining cellular chemosensitivity
05/25/17Dihydropteridinone derivatives and uses thereof
05/25/17Diazepane derivatives and uses thereof
05/25/17Methods for the treatment of infections and tumors
05/18/17Systems, apparatus, and methods related to magnetically-controlled three-dimensional tissue cultures
05/11/17Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
04/27/17Protein-based particles for drug delivery
04/27/17Uses of kinase inhibitors for inducing and maintaining pluripotency
04/27/17Compositions and methods for targeting cancer-specific sequence variations
04/27/17Activating jak kinase biomarkers predictive of anti-immune checkpoint inhibitor response
03/23/17Stabilized p53 peptides and uses thereof
03/23/17Method and kits for determining sensitivity to cancer treatment
03/16/17Compositions and methods for regulating pancreatic beta cell function using adipsin
03/16/17Humanized monoclonal antibodies and methodsof use
03/09/17Bpi and its congeners as radiation mitigators and radiation protectors
03/02/17Bpi and its congeners as radiation mitigators and radiation protectors
02/23/17Fusion proteins for treating cancer and related methods
02/23/17Compositions and methods for identification, assessment, prevention, and treatment of cancer using nfs1 biomarkers and modulators
02/16/17Combination vaccine devices and methods of killing cancer cells
02/16/17Janus kinase inhibitors and uses thereof
02/16/17Hydrophobically tagged janus kinase inhibitors and uses thereof
02/16/17Humanized monoclonal antibodies and methods of use
02/16/17High-throughput structure determination using nucleic acid calipers
02/09/17Methods for predicting anti-cancer response
02/02/17Compositions and methods for treating neoplasia, inflammatory disease and other disorders
02/02/17Ddr2 mutations in squamous cell lung cancer
01/26/17Therapeutic peptides
01/19/17Stabilized anti-microbial peptides
01/12/17Uses of diazepane derivatives
01/12/17Therapeutic peptides
01/05/17Vaccine compositions and methods for restoring nkg2d pathway function against cancers
12/22/16Compositions and methods for sensitizing a neoplastic cell to radiation
Patent Packs
12/22/16Inhibitors of c-jun-n-terminal kinase (jnk)
12/15/16Cd4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies
12/15/16Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
12/15/16Signatures and determinants associated with prostate cancer progression and methods of use thereof
12/01/16Diazepane derivatives and uses thereof
12/01/16Dihydropteridinone derivatives and uses thereof
12/01/16Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
12/01/16Agents that modulate rgmb-neogenin-bmp signaling and methods of use thereof
11/24/16Combination therapy with neoantigen vaccine
11/24/16Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
11/17/16Diaminopyrimidine benzenesulfone derivatives and uses thereof
11/17/16Compositions and methods of identifying tumor specific neoantigens
11/17/16Diaminopyrimidine benzenesulfone derivatives and uses thereof
11/10/16Compositions and methods for diagnosing, evaluating and treating cancer
11/03/16Male contraceptive compositions and methods of use
Patent Packs
11/03/16Methods to treat lymphoplasmacytic lymphoma
10/27/16Methods to treat lymphoplasmacytic lymphoma
10/20/16Methods to distinguish waldenstrom's macroglobulinemia from igm monoclonal gammopathy of undetermined significance
10/20/16Methods to distinguish waldenstrom's macroglobulinemia from igm monoclonal gammopathy of undetermined significance
10/20/16Compositions and methods for identifying and treating cachexia or pre-cachexia
10/13/16Methods of treating cancer with atovaquone-related compounds
10/13/16Controlled delivery of tlr agonists in structural polymeric devices
10/13/16Polymorphic gene typing and somatic change detection using sequencing data
10/13/16Kynurenine pathway biomarkers predictive of anti-immune checkpoint inhibitor response
10/06/16Composition and methods of genome editing of b-cells
10/06/16Biomarker for melk activity and methods of using same
09/29/16Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
09/29/16Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
09/22/16Anti-pd-l1 monoclonal antibodies and fragments thereof
09/22/16Nucleic acid nanostructures for in vivo agent delivery
09/22/16Inhibitors of histone deacetylase
09/22/16Treatment of c1013g/cxcr4-associated waldenstrÖm's macroglobulinemia with an anti-cxcr4 antibody
09/15/16Heteroaromatic compounds useful for the treatment of prolferative diseases
09/15/16Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
09/15/16Pyrazol-3-ones that activate pro-apoptotic bax
09/08/16Methods of determining cellular chemosensitivity
08/25/16Methods to induce targeted protein degradation through bifunctional molecules
08/18/16Methods to induce targeted protein degradation through bifunctional molecules
08/18/16Methods to induce targeted protein degradation through bifunctional molecules
08/18/16Compositions and methods for the treatment of viral infections
08/11/16Continuous cell programming devices
08/11/16Methods of bh3 profiling
08/04/16Methods for evaluating and treating waldenstrom's macroglobulinemia
08/04/16Methods of assessing tumor growth
08/04/16Continuous cell programming devices
Social Network Patent Pack
08/04/16Continuous cell programming devices
08/04/16Methods for evaluating and treating waldenstrom's macroglobulinemia
07/28/16Methods for the identification, assessment, prevention, and treatment of neurological disorders and diseases using fndc5
07/28/16Anti-galectin-1 (gal1) monoclonal antibodies and fragments thereof for neutralizing gal1
07/14/16Bh3 peptides and methods of use thereof
07/07/16Compositions and methods for identification, assessment, prevention, and treatment of cancer using histone h3k27me3 biomarkers and modulators
06/30/16Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
06/30/16Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of use
06/30/16Methods and compositions to enable enrichment of minor dna alleles by limiting denaturation time in pcr or simply enable enrichment of minor dna alleles by limiting the denaturation time in pcr
06/30/16Compositions, kits, and methods for the modulation of immune responses using galectin-1
Patent Packs
06/23/16Compoitions and methods for modulating thermogenesis using pth-related and egf-related compounds
06/23/16Prevention of type 1 diabetes by treg vaccination with an insulin mimetope
06/23/16Kinase inhibitors for the treatment of disease
06/23/16Methods to induce targeted protein degradation through bifunctional molecules
06/23/16Humanized monoclonal antibodies and methods of use
06/16/16Inhibitors of transcription factors and uses thereof
06/16/16Anti-galectin-1 monoclonal antibodies and fragments thereof
06/16/16Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
06/09/16Stabilized insulinotropic peptides and methods of use
06/02/16Compositions and methods for the treatment of viral infections
06/02/16Compositions and methods for treating cancer
05/26/16Histone deacetylase inhibitors
05/26/16Compositions and methods for treating cancer
05/26/16Dot1l probes
05/19/16Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
05/19/16Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
05/19/16Non-invasive blood based monitoring of genomic alterations in cancer
05/19/16Oncogene associated with human cancers and methods of use thereof
05/05/16Inhibitors of cyclin-dependent kinase 7 (cdk7)
05/05/16Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
05/05/16Methods and compositions for reducing immunosupression by tumor cells
05/05/16Cancer diagnosis, treatment selection and treatment
05/05/16Compositions and methods for identification, assessment, prevention, and treatment of cancer using pd-l1 isoforms
04/21/16V3 immunogens
04/21/16Antibody molecules to pd-l1 and uses thereof
04/14/16Compositions and methods for personalized neoplasia vaccines
04/07/16Bet inhibition therapy for heart disease
04/07/16Compositions and methods for induced brown fat differentiation
03/24/16Wireframe nanostructures
03/24/16Methods for determining response to a hypomethylating agent
Patent Packs
03/24/16Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
03/17/16Method of attenuating reactions to skin irritants
03/17/16Combination anti-her2 cancer therapy using muc1 peptides and chemotherapeutics
03/10/16Stablized ezh2 peptides
03/03/16Combination anti-estrogen receptor cancer therapy using muc1 peptides and chemotherapeutics
03/03/16Dot1l inhibitors
02/25/16Treatment of protein degradation disorders
02/18/16Type ii raf kinase inhibitors
02/18/16Ras inhibitors and uses thereof
02/18/16Stabilized sos1 peptides
02/18/16Therapeutic peptides
02/18/16Methods and systems for treatment of ovarian cancer
02/04/16Bh4 stabilized peptides and uses thereof
02/04/16Substituted heterocyclic compounds for treating or preventing viral infections
02/04/16Methods for generating nucleic acid molecule fragments having a customized size distribution
02/04/16Bromodomain binding reagents and uses thereof
01/28/16Pyrimido-diazepinone compounds and methods of treating disorders
01/28/16Flavivirus neutralizing antibodies and methods of use thereof
01/28/16Lna antisense oligonucleotides for the modulation of myc expression
01/28/16Methods of identifying responses to map kinase inhibition therapy
Social Network Patent Pack
01/14/16Compositions and methods of identifying tumor specific neoantigens
01/14/16Xbp1, cd138, and cs1 peptides
12/17/15Dynamic bh3 profiling
12/10/15Selective histone deacetylase 8 inhibitors
12/10/15Melk regulation for the treatment of breast cancer
12/10/15Markers for acute lymphoblastic leukemia
11/19/15Methods for treatment of melanoma
11/19/15Metabolomic profiling defines oncogenes driving prostate tumors
11/12/15Biomarkers associated with cdk inhibitors
11/12/15Compositions and methods for regulating thermogenesis and muscle inflammation using metrnl and metrn
11/12/15Compositions and methods for diagnosis, prognosis and treatment of hematological malignanicies
11/05/15Kinase inhibitors and methods of use thereof
11/05/15Composition and treating a hematological malignancy
11/05/15Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders
10/29/15Methods for treatment of melanoma
10/29/15Class- and isoform-specific hdac inhibitors and uses thereof
10/29/15Metabolic profiling in tissue and serum is indicative of tumor differentiation in prostate cancer
10/22/15Compositions and methods for inhibiting viral entry
10/22/15Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions
10/22/15Agents that modulate immune cell activation and methods of use thereof
Social Network Patent Pack
10/15/15Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
10/15/15Method of determining cancer prognosis
10/08/15Methods for treating, preventing and predicting risk of developing breast cancer
10/01/15Hydrophobically tagged small molecules as inducers of protein degradation
10/01/15Human monoclonal anti-pd-l1 antibodies and methods of use
10/01/15Hydrophobically tagged small molecules as inducers of protein degradation
09/10/15Targeted expansion of qa-1-peptide-specific regulatory cd8 t cells to ameliorate arthritis
09/10/15Novel targets in multiple myeloma and other disorders
09/03/15Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
09/03/15Methods and compositions for specific modulation of mcl-1
08/27/15Methods for the treatment of infections and tumors
08/06/15Self-assembly of nucleic acid nanostructures
08/06/15Antibody molecules to tim-3 and uses thereof
07/30/15Antibody molecules to pd-1 and uses thereof
07/23/15Compositions and methods for brown fat induction and activity using fndc5
07/16/15Selective inhibitors of histone deacetylase isoform 6 and methods thereof
07/16/15Single agent anti-pd-l1 and pd-l2 dual binding antibodies and methods of use
07/16/15Methods and analyzing and quantifying dna alterations in cancer
07/09/15Anti-proliferative compounds and uses thereof
07/09/15Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
07/02/15Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
06/25/15Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
06/25/15Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
06/18/15Host targeted inhibitors of dengue virus and other viruses
06/18/15Genome-wide assessing interactions between chemical entities and their target molecules
06/11/15Type ii raf kinase inhibitors
06/04/15Compositions and methods for treating neoplasia, inflammatory disease and other disorders
06/04/15Muc-1 cytoplasmic domain peptides as inhibitors of cancer
05/21/15Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy
05/14/15C-raf mutants that confer resistance to raf inhibitors
Social Network Patent Pack
05/07/15Methods for diagnosing and treating oncogenic kras-associated cancer
04/30/15Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of use
04/30/15Stabilized p53 peptides and uses thereof
04/23/15Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
04/23/15Methods of treating a meiotic kinesin-associated disease
04/02/15Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof
04/02/15Small molecule myristate inhibitors of bcr-abl and methods of use
04/02/15Fused 2-aminothiazole compounds
03/26/15Treating muc1-expressing cancers with helicase inhibitors
03/05/15Methods of treating cancer having an active wnt/beta-catenin pathway
02/26/15Compositions and methods for sensitizing a neoplastic cell to radiation
02/19/15Isolation and use of human lymphoid organ-derived suppressive stromal cells
02/19/15Inhibition of mcl-1 and/or bfl-1/a1
02/12/15Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
02/12/15Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
02/12/15Compositions and methods of treating cancer
02/12/15Sik inhibitor for use in a treating an inflammatory and/or immune disorder
02/05/15Methods for predicting anti-cancer response
01/22/15Modulation of tim receptor activity in combination with cytoreductive therapy
01/15/15Compositions and methods for the modulation of dna damage responses using bal1 and bbap
01/01/15Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer
12/25/14Lkb1/stk11 deletion in melanoma and related methods
12/25/14Collateral gene inactivation biomarkers and targets for cancer therapy
12/18/14Stabilized antiviral fusion helices
12/18/14Methods of downregulating translocated oncogene expression using bromodomain inhibitors
12/11/14Markers associated with chronic lymphocytic leukemia prognosis and progression
11/06/14Lin28-mediated control of let-7 biogenesis
10/30/14Antagonists of muc1
10/23/14Signatures and determinants associated with prostate cancer progression and methods of use thereof







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dana farber Cancer Institute Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dana farber Cancer Institute Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';